Explore
← New search
13 matching publication(s)
Targeting the epigenome and the integrated stress response to normalize colorectal cancer subclonal plasticity and progression.
PMID 41963303 · Cell Death Dis · 2026
L1
68/100
Single-Cell Transcriptomic Landscape of Right-Sided Colon Cancer Reveals Cellular and Molecular Features of Metastatic Potential.
PMID 41898210 · Biomedicines · 2026
L1
71/100
Enhancing cell subpopulation discovery in cancer by integrating single-cell transcriptome and expressed variants.
PMID 41647537 · Fundam Res · 2025
L1
68/100
Identification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers.
PMID 39779736 · Sci Rep · 2025
L1
74/100
Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer.
PMID 39572705 · Commun Biol · 2024
L1
68/100
A platelet-related signature for predicting the prognosis and immunotherapy benefit in bladder cancer based on machine learning combinations.⚑
PMID 39280688 · Transl Androl Urol · 2024
L1
51/100
⚑
Involvement of N4BP2L1, PLEKHA4, and BEGAIN genes in breast cancer and muscle cell development.
PMID 38859961 · Front Cell Dev Biol · 2024
L1
73/100
Research and experimental verification on the mechanisms of cellular senescence in triple-negative breast cancer.
PMID 38435998 · PeerJ · 2024
L1
67/100
Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer.
PMID 38076064 · Heliyon · 2023
L1
71/100
Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma.
PMID 37161060 · Sci Rep · 2023
L1
73/100
Clustering and machine learning-based integration identify cancer associated fibroblasts genes' signature in head and neck squamous cell carcinoma.
PMID 37065499 · Front Genet · 2023
L1
63/100
Artificial intelligence-guided discovery of gastric cancer continuum.
PMID 36692601 · Gastric Cancer · 2023
L1
71/100
Qualitative Transcriptional Signature for the Pathological Diagnosis of Pancreatic Cancer.
PMID 33173782 · Front Mol Biosci · 2020
L1
71/100